- Home
- PHAT vs CLPT Comparison
PHAT vs CLPT Comparison
Compare PHAT & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- CLPT
- Stock Information
- Founded
- PHAT 2018
- CLPT 1998
- Country
- PHAT United States
- CLPT United States
- Employees
- PHAT N/A
- CLPT N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- PHAT Health Care
- CLPT Health Care
- Exchange
- PHAT Nasdaq
- CLPT Nasdaq
- Market Cap
- PHAT 465.0M
- CLPT 412.7M
- IPO Year
- PHAT 2019
- CLPT N/A
- Fundamental
- Price
- PHAT $6.96
- CLPT $15.04
- Analyst Decision
- PHAT Strong Buy
- CLPT Strong Buy
- Analyst Count
- PHAT 4
- CLPT 2
- Target Price
- PHAT $23.00
- CLPT $12.00
- AVG Volume (30 Days)
- PHAT 971.9K
- CLPT 198.6K
- Earning Date
- PHAT 03-06-2025
- CLPT 03-11-2025
- Dividend Yield
- PHAT N/A
- CLPT N/A
- EPS Growth
- PHAT N/A
- CLPT N/A
- EPS
- PHAT N/A
- CLPT N/A
- Revenue
- PHAT $26,270,000.00
- CLPT $30,429,000.00
- Revenue This Year
- PHAT $7,622.43
- CLPT $35.56
- Revenue Next Year
- PHAT $236.87
- CLPT $21.86
- P/E Ratio
- PHAT N/A
- CLPT N/A
- Revenue Growth
- PHAT N/A
- CLPT 36.34
- 52 Week Low
- PHAT $6.07
- CLPT $5.11
- 52 Week High
- PHAT $19.71
- CLPT $17.47
- Technical
- Relative Strength Index (RSI)
- PHAT 37.02
- CLPT 51.20
- Support Level
- PHAT $6.36
- CLPT $14.75
- Resistance Level
- PHAT $7.20
- CLPT $15.93
- Average True Range (ATR)
- PHAT 0.48
- CLPT 0.78
- MACD
- PHAT 0.08
- CLPT -0.18
- Stochastic Oscillator
- PHAT 30.48
- CLPT 33.78
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.